CN
Innovative Treatments for Neurodegenerative Diseases

Join more than 4,000 pharma, biotech, nonprofit and academic collaborators who trust our platform. Access our end to end solutions in small molecule, peptide and oligonucleotide drug discovery and development.

Enabling Discovery for Neurodegenerative Diseases

     

     

Enabling Unbounded Possibilities

The WuXi AppTec Research Service Division (RSD) supports clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, RSD works collaboratively to rapidly advance programs from target through to preclinical selection and beyond.

     

     

Business Contact: